ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
ImmunoPrecise Antibodies Ltd

ImmunoPrecise Antibodies Ltd (IPA)

6.50
0.00
(0.00%)
終了 1月18日 6:00AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
6.50
買値
6.31
売値
6.75
出来高
-
0.00 日の範囲 0.00
6.50 52 週間の範囲 6.50
時価総額
前日終値
6.50
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
26,944,000
配当利回り
-
PER
-0.53
1 株当たり利益 (EPS)
-1.01
歳入
24.52M
純利益
-27.18M

ImmunoPrecise Antibodies Ltd について

セクター
Pharmaceutical Preparations
業界
Miscellaneous Metal Ores,nec
ウェブサイト
本社
Victoria, British Columbia, Can
設立
2016
ImmunoPrecise Antibodies Ltd is listed in the Pharmaceutical Preparations sector of the トロントベンチャー取引所 with ticker IPA. The last closing price for ImmunoPrecise Antibodies was $6.50. Over the last year, ImmunoPrecise Antibodies shares have traded in a share price range of $ 6.50 to $ 6.50.

ImmunoPrecise Antibodies currently has 26,944,000 shares in issue. The market capitalisation of ImmunoPrecise Antibodies is $175.14 million. ImmunoPrecise Antibodies has a price to earnings ratio (PE ratio) of -0.53.

IPA 最新ニュース

IPA's Subsidiary BioStrand Secures Second VLAIO Research Grant

IPA's Subsidiary BioStrand Secures Second VLAIO Research GrantIPA subsidiary BioStrand receives grant to expand LENSai platform by linking HYFTs™ with 3D protein structure and...

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue - Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and Offerings

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue – Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and...

IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence

IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence New Platform...

IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of Defense

                   IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of...

IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03

 IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03 In vivo, IND enabling evaluations of PolyTope® TATX-03 in animal model show:There were no...

ImmunoPrecise lance le programme d'anticorps candidat TATX-112 pour le traitement du cancer et de la maladie d'Alzheimer

Traitement potentiel de la maladie de Parkinson et d'autres affections neurodégénératives IMMUNOPRECISE ANTIBODIES LTD. (la "Société" ou "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) un chef de file...

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease

   ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease   Potential to Treat Parkinson's and Other...

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease

Potential to Treat Parkinson’s and Other Neurodegenerative Diseases IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic...

ImmunoPrecise identifie un anticorps unique, le 23-H7, qui démontre une efficacité in vivo, un mécanisme d'action alternat...

L'anticorps bloque l'interaction de liaison DFR/ACE2 par le biais d'un mécanisme d'action alternatif L'anticorps se lie à tous les variants préoccupants testés, probablement parce qu'il cible un...

ImmunoPrecise Identifies a Unique Antibody, 23-H7, That Demonstrates In Vivo Efficacy, an Alternative Mechanism of Action & B...

Blocks the RBD/ACE2 binding interaction indirectly through an alternative mechanism of action Binds to all tested variants of concern, likely because it targets a site other than the mutation...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1006.56.56.500CS
4006.56.56.500CS
12006.56.56.500CS
26006.56.56.500CS
52006.56.56.500CS
156-1.6-19.75308641988.18.444.5256966.28060538CS
2605.911001.694915250.5926.250.55724184.0963285CS

IPA - Frequently Asked Questions (FAQ)

What is the current ImmunoPrecise Antibodies share price?
The current share price of ImmunoPrecise Antibodies is $ 6.50
How many ImmunoPrecise Antibodies shares are in issue?
ImmunoPrecise Antibodies has 26,944,000 shares in issue
What is the market cap of ImmunoPrecise Antibodies?
The market capitalisation of ImmunoPrecise Antibodies is CAD 175.14M
What is the 1 year trading range for ImmunoPrecise Antibodies share price?
ImmunoPrecise Antibodies has traded in the range of $ 6.50 to $ 6.50 during the past year
What is the PE ratio of ImmunoPrecise Antibodies?
The price to earnings ratio of ImmunoPrecise Antibodies is -0.53
What is the cash to sales ratio of ImmunoPrecise Antibodies?
The cash to sales ratio of ImmunoPrecise Antibodies is 0.58
What is the reporting currency for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies reports financial results in CAD
What is the latest annual turnover for ImmunoPrecise Antibodies?
The latest annual turnover of ImmunoPrecise Antibodies is CAD 24.52M
What is the latest annual profit for ImmunoPrecise Antibodies?
The latest annual profit of ImmunoPrecise Antibodies is CAD -27.18M
What is the registered address of ImmunoPrecise Antibodies?
The registered address for ImmunoPrecise Antibodies is 3204 - 4464 MARKHAM STREET, VICTORIA, BRITISH COLUMBIA, V8Z 7X8
What is the ImmunoPrecise Antibodies website address?
The website address for ImmunoPrecise Antibodies is www.immunoprecise.com
Which industry sector does ImmunoPrecise Antibodies operate in?
ImmunoPrecise Antibodies operates in the MISCELLANEOUS METAL ORES,NEC sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AHRAmarc Resources Ltd
$ 0.72
(171.70%)
4.17M
OEG.HONEnergy Inc
$ 0.035
(133.33%)
14.66k
FYLFinlay Minerals Ltd
$ 0.045
(125.00%)
4.86M
CPICarlton Precious Inc
$ 0.16
(113.33%)
1,000
MVYMoovly Media Inc
$ 0.01
(100.00%)
1.5M
GAR.HGreen Arrow Resources Inc
$ 0.015
(-66.67%)
1.96k
CANDCandelaria Mining Corp
$ 0.005
(-50.00%)
553.7k
WWTWater Ways Technologies Inc
$ 0.005
(-50.00%)
79.65k
AZC.PA2ZCryptocap Inc
$ 0.045
(-50.00%)
33k
BYM.HBaymount Incorporated
$ 0.005
(-50.00%)
5k
FYLFinlay Minerals Ltd
$ 0.045
(125.00%)
4.86M
AGMRSilver Mountain Resources Inc
$ 0.05
(-9.09%)
4.23M
AHRAmarc Resources Ltd
$ 0.72
(171.70%)
4.17M
TDGTDG Gold Corp
$ 0.245
(75.00%)
4.08M
MATEBlockmate Ventures Inc
$ 0.33
(0.00%)
3.99M

最近閲覧した銘柄

Delayed Upgrade Clock